Polyphenol‐containing nanoparticles: synthesis, properties, and therapeutic delivery

Y Guo, Q Sun, FG Wu, Y Dai, X Chen - Advanced Materials, 2021 - Wiley Online Library
Polyphenols, the phenolic hydroxyl group‐containing organic molecules, are widely found in
natural plants and have shown beneficial effects on human health. Recently, polyphenol …

Cisplatin: The first metal based anticancer drug

S Ghosh - Bioorganic chemistry, 2019 - Elsevier
Abstract Cisplatin or (SP-4-2)-diamminedichloridoplatinum (II) is one of the most potential
and widely used drugs for the treatment of various solid cancers such as testicular, ovarian …

[HTML][HTML] Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: A review

S Hossen, MK Hossain, MK Basher, MNH Mia… - Journal of advanced …, 2019 - Elsevier
Nonspecific distribution and uncontrollable release of drugs in conventional drug delivery
systems (CDDSs) have led to the development of smart nanocarrier-based drug delivery …

DNA vaccines—how far from clinical use?

D Hobernik, M Bros - International journal of molecular sciences, 2018 - mdpi.com
Two decades ago successful transfection of antigen presenting cells (APC) in vivo was
demonstrated which resulted in the induction of primary adaptive immune responses. Due to …

Advancements in dextran-based nanocarriers for treatment and imaging of breast cancer

MS Khan, BHJ Gowda, N Nasir, S Wahab… - International journal of …, 2023 - Elsevier
Breast cancer is the most prevalent type of cancer worldwide, particularly among women,
with substantial side effects after therapy. Despite the availability of numerous therapeutic …

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

I Tombácz, D Laczkó, H Shahnawaz, H Muramatsu… - Molecular Therapy, 2021 - cell.com
Nucleoside-modified messenger RNA (mRNA)-lipid nanoparticles (LNPs) are the basis for
the first two EUA (Emergency Use Authorization) COVID-19 vaccines. The use of nucleoside …

[HTML][HTML] Electrospinning technologies for the delivery of Biopharmaceuticals: Current status and future trends

S Lian, D Lamprou, M Zhao - International Journal of Pharmaceutics, 2024 - Elsevier
This review provides an in-depth exploration of electrospinning techniques employed to
produce micro-or nanofibres of biopharmaceuticals using polymeric solutions or melts with …

Unlocking the potential of mesoporous silica nanoparticles in breast cancer treatment

R Thapa, H Ali, O Afzal, AA Bhat, WH Almalki… - Journal of Nanoparticle …, 2023 - Springer
Breast cancer is the most common cancer among women and is typically managed through
surgery, radiation therapy, and chemotherapy. However, chemotherapy drugs often lack …

Mesoporous silica nanoparticles: synthesis, pharmaceutical applications, biodistribution, and biosafety assessment

F Farjadian, A Roointan, S Mohammadi-Samani… - Chemical Engineering …, 2019 - Elsevier
Mesoporous silica nanoparticles (MSNs) are a key example of the innovation in material
science to develop nanotechnology-based delivery systems. Biological and pharmaceutical …

Persistent luminescence nanoparticles for cancer theranostics application

N Liu, X Chen, X Sun, X Sun, J Shi - Journal of Nanobiotechnology, 2021 - Springer
Persistent luminescence nanoparticles (PLNPs) are unique optical materials that emit
afterglow luminescence after ceasing excitation. They exhibit unexpected advantages for in …